PhD conferral Ms Yang Yu, MSc.
Supervisors: prof.dr. C. Neef, prof.dr. D. Burger
Co-supervisor: dr. M. Maliepaard
“Towards understanding interchangeability of generic drugs”
Key words: generic drug, brand-name drug, interchangeability, bioequivalence
Registered generic drugs are considered interchangeable with brand-name drugs. However, concerns still exist in practice. In this dissertation, the role of individual-subject variation in the drug absorption and the effect of post-marketing drug quality changes were studied for generic and the brand-name drug interchangeability. Generic-generic drug interchangeability was studied in a clinical trial and inter-study comparisons. In conclusion, interchanges of generic to the brand-name drugs or generic to other generic drugs can be applied in clinical practice without clinical consequences. Current regulation for registration of a generic drug in Europe is reasonably strict to ensure the bioequivalence of the generic drug with the brand-name drug.
Also read
-
PhD defence Louise David
" The Effort of Change: Understanding and Supporting Students’ Sustainable Use of Effective Learning Strategies"PhD defence18 May -
PhD defence Jayendra Sharma
" Universal health coverage in Bhutan: an empirical enquiry"PhD defence18 May -
PhD defence Céline Johanna Angelique van Bilsen
" Mapping COVID-19 Impact: Cross-border Mobility, Social Networks, Vaccination, and Post-COVID Condition"PhD defence19 May